ODYS · Odysight.ai Inc. · Insider Trading

On August 20, 2026, the Reporting Person acquired 1,125,000 shares of common stock in the Issuer's underwritten public offering of shares of common stock for an offering price of $3.20 per share of common stock.

On August 20, 2026, the Reporting Person's spouse acquired 46,875 shares of common stock in the Issuer's underwritten public offering of shares of common stock for an offering price of $3.20 per share of common stock.

Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

On August 20, 2026, the Reporting Person acquired 31,250 shares of common stock in the Issuer's underwritten public offering of shares of common stock for a offering price of $3.20 per share of common stock.

The stock option vests and becomes exercisable as to one-third of the total shares on May 19, 2027 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on May 19, 2029.

The cashless exercise of the warrant to purchase common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

On March 25, 2026, Phoenix Insurance Company Ltd. exercised a warrant to purchase 2,352,941 shares of the Issuer's common stock for $5.50 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer withholding 2,081,044 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 271,897 shares.

On March 25, 2026, Phoenix Insurance Company Ltd. exercised a warrant to purchase 2,352,941 shares of the Issuer's common stock for $5.50 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer withholding 2,081,044 of the warrant shares to pay the exercise price and issuing to the Reporting Person the remaining 271,897 shares.

The cashless exercise of the warrant to purchase common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors.

On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the "old" options and the grant of "replacement" options.

On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the "old" options and the grant of "replacement" options.

On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the "old" options and the grant of "replacement" options.

On February 19, 2026, the Board of Directors of the Company approved a three-year extension of the term of the options held by the reporting person, resulting in the cancellation of the "old" options and the grant of "replacement" options.

The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.18 to $3.38, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 represents a weighted-average price. All shares were sold in multiple transactions at the same price of $3.44. The reporting person undertakes to provide, upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each transaction.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.40, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 represents a weighted-average price. All shares were sold in multiple transactions at the same price of $3.35. The reporting person undertakes to provide, upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each transaction.

The price reported in Column 4 represents a weighted-average price. All shares were sold in multiple transactions at the same price of $2.81. The reporting person undertakes to provide, upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each transaction.

The price reported in Column 4 represents a weighted-average price. All shares were sold in multiple transactions at the same price of $3.38. The reporting person undertakes to provide, upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each transaction.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.82, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 represents a weighted-average price. All shares were sold in multiple transactions at the same price of $3.53. The reporting person undertakes to provide, upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each transaction.

The stock option vests and becomes exercisable as to one-third of the total shares on September 17, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on September 17, 2028.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.89 to $5.93, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

The stock option vests and becomes exercisable as to one-third of the total shares on March 10, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on March 10, 2028.

This transaction involved the Reporting Person's gift of 75,000 shares of common stock of Odysight.ai Inc. to his spouse. The Reporting Person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

This transaction involved the Reporting Person's gift of 75,000 shares of common stock of Odysight.ai Inc. to his spouse. The Reporting Person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.